The Physiologic Effects of Pain on the Endocrine System

Severe pain has profound physiologic effects on the endocrine system. Serum hormone abnormalities may result and these serve as biomarkers for the presence of severe pain and the need to replace hormones to achieve pain control. Initially severe pain causes a hyperarousal of the hypothalamic–pituitary–adrenal system which results in elevated serum hormone levels such as adrenocorticotropin, cortisol, and pregnenolone. If the severe pain does not abate, however, the system cannot maintain its normal hormone production and serum levels of some hormones may drop below normal range. Some hormones are so critical to pain control that a deficiency may enhance pain and retard healing.

[1]  H. Daniell Hypogonadism in men consuming sustained-action oral opioids. , 2002, The journal of pain : official journal of the American Pain Society.

[2]  G. Chrousos,et al.  The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.

[3]  L. Nieman,et al.  Cushing's syndrome , 2005 .

[4]  H. Daniell DHEAS deficiency during consumption of sustained-action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production. , 2006, The journal of pain : official journal of the American Pain Society.

[5]  N. Holbrook,et al.  Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. , 1984, Endocrine reviews.

[6]  E. Griep,et al.  Glucocorticoid receptors, fibromyalgia and low back pain , 1997, Psychoneuroendocrinology.

[7]  M. Sofroniew,et al.  Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Sapolsky,et al.  Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. , 1990, Neuroendocrinology.

[9]  M. Joëls,et al.  Control of neuronal excitability by corticosteroid hormones , 1992, Trends in Neurosciences.

[10]  P. McHardy,et al.  Pulsed Radiofrequency Under Ultrasound Guidance for Persistent Stump‐Neuroma Pain , 2011, Pain practice : the official journal of World Institute of Pain.

[11]  P. Evans,et al.  Increased cortisol excretion in chronic pain , 1983, Anaesthesia.

[12]  L. Guth,et al.  Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Dubner,et al.  Progesterone attenuates persistent inflammatory hyperalgesia in female rats: involvement of spinal NMDA receptor mechanisms , 2000, Brain Research.

[14]  C. Bologna,et al.  Dysregulation of the hypothalamo-pituitary axis in rheumatoid arthritis. , 1995, The Journal of rheumatology.

[15]  T. Kral,et al.  The immune-hypothalamic-pituitary-adrenal axis. , 1989, Endocrine reviews.

[16]  A. Gintzler,et al.  Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms , 1996, Pain.

[17]  H. Akil,et al.  Induction of the intermediate pituitary by stress: synthesis and release of a nonopioid form of beta-endorphin. , 1985, Science.

[18]  C. H. Tambeli,et al.  The protective role of testosterone in the development of temporomandibular joint pain. , 2007, The journal of pain : official journal of the American Pain Society.

[19]  G. Cavaletti,et al.  Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: A multimodal analysis , 2007, Neuroscience.

[20]  R. Rizza,et al.  Effects of glucocorticoids on carbohydrate metabolism. , 1988, Diabetes/metabolism reviews.

[21]  L. Sonkin Therapeutic trials with thyroid hormones in chemically euthyroid patients with myofascial pain and complaints suggesting mild thyroid insufficiency. , 1997, Journal of back and musculoskeletal rehabilitation.

[22]  Russell Ij Neurohormonal aspects of fibromyalgia syndrome. , 1989 .

[23]  H. Shenkin The effect of pain on the diurnal pattern of plasma corticoid levels , 1964, Neurology.

[24]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[25]  J. van Buyten,et al.  Endocrine consequences of long-term intrathecal administration of opioids. , 2000, The Journal of clinical endocrinology and metabolism.

[26]  K. Federlin,et al.  Adrenal secretion of cortisol in patients with rheumatoid arthritis. , 1990, The Journal of rheumatology.

[27]  A. Mensah-Nyagan,et al.  Biochemical and functional evidence for the control of pain mechanisms by dehydroepiandrosterone endogenously synthesized in the spinal cord , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  M. Max,et al.  Effects of chronic osteoarthritis pain on neuroendocrine function in men. , 2006, The Journal of clinical endocrinology and metabolism.

[29]  K. Stafford,et al.  A comparison of catecholamine and cortisol responses of young lambs and calves to painful husbandry procedures. , 2002, Australian veterinary journal.

[30]  K. Ørstavik,et al.  Pain and small-fiber neuropathy in patients with hypothyroidism , 2006, Neurology.

[31]  G. Besser,et al.  OPIATE MODULATION OF THE PITUITARY‐ADRENAL AXIS: EFFECTS OF STRESS AND CIRCADIAN RHYTHM , 1982, Clinical endocrinology.

[32]  J. Holaday,et al.  Adrenal steroids indirectly modulate morphine and beta-endorphin effects. , 1979, The Journal of pharmacology and experimental therapeutics.

[33]  B. Sherman,et al.  Decreased glucocorticoid receptor binding in adrenal insufficiency. , 1982, The Journal of clinical endocrinology and metabolism.

[34]  J. Holaday,et al.  Blood-brain barrier: endogenous modulation by adrenal-cortical function. , 1985, Science.

[35]  R. Straub,et al.  Involvement of the hypothalamic--pituitary--adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. , 2001, Arthritis and rheumatism.

[36]  J. Newell-Price,et al.  Cushing's syndrome. , 2009, Nursing mirror.

[37]  L. Hermann,et al.  Normalization of serum cortisol concentration with opioid treatment of severe chronic pain. , 2002, Pain medicine.

[38]  D. Farb,et al.  Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. , 1991, Molecular pharmacology.

[39]  L. J. Roberts,et al.  Hypogonadism in patients treated with intrathecal morphine. , 2000, The Clinical journal of pain.

[40]  H. Moldofsky,et al.  The neuroscience and endocrinology of fibromyalgia. , 1997, Arthritis and rheumatism.

[41]  A B Atkinson,et al.  Diagnosis and complications of Cushing's syndrome: a consensus statement. , 2003, The Journal of clinical endocrinology and metabolism.

[42]  B. McEwen,et al.  Adrenal steroid receptors and actions in the nervous system. , 1986, Physiological reviews.

[43]  L. J. Roberts,et al.  Sex Hormone Suppression by Intrathecal Opioids: A Prospective Study , 2002, The Clinical journal of pain.

[44]  I. Russell Neurohormonal aspects of fibromyalgia syndrome. , 1989, Rheumatic diseases clinics of North America.

[45]  E. D. de Kloet,et al.  Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. , 1998, The Journal of rheumatology.

[46]  L. Krakoff Glucocorticoid excess syndromes causing hypertension. , 1988, Cardiology clinics.

[47]  A. Friedhoff,et al.  The effect of hyperthyroidism on opiate receptor binding and pain sensitivity. , 1990, Life sciences.

[48]  K. Jones Gonadal steroids and neuronal regeneration. A therapeutic role. , 1993, Advances in neurology.

[49]  S. Lightman,et al.  A protective role for testosterone in adjuvant-induced arthritis. , 1995, British journal of rheumatology.

[50]  A. Aloisi,et al.  Testosterone affects formalin-induced responses differently in male and female rats , 2004, Neuroscience Letters.

[51]  F. L. Moore,et al.  A corticosteroid receptor in neuronal membranes. , 1991, Science.

[52]  Youichi Yamasaki,et al.  Neuroendocrine responses to psychological stress in patients with myofascial pain. , 2005, Journal of orofacial pain.

[53]  L. Crofford,et al.  Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. , 2000, Rheumatic diseases clinics of North America.

[54]  G. Lauria,et al.  Painful neuropathy in subclinical hypothyroidism: clinical and neuropathological recovery after hormone replacement therapy , 2009, Neurological Sciences.

[55]  A. Aloisi,et al.  Chronic pain therapy and hypothalamic-pituitary-adrenal axis impairment , 2011, Psychoneuroendocrinology.

[56]  K. Rice,et al.  Gonadal hormone modulation of mu, kappa, and delta opioid antinociception in male and female rats. , 2005, The journal of pain : official journal of the American Pain Society.

[57]  C. Glynn,et al.  Biochemical changes associated with intractable pain. , 1978, British medical journal.

[58]  F. Dhabhar,et al.  The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions , 1997, Brain Research Reviews.

[59]  B. McEwen,et al.  Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[60]  G. Kingsley,et al.  Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. , 1992, Arthritis and rheumatism.

[61]  H. Daniell Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. , 2008, The journal of pain : official journal of the American Pain Society.

[62]  M. Cutolo,et al.  Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. , 1999, The Journal of rheumatology.

[63]  M. Grauer,et al.  [Altered function of the hypothalamic-pituitary-adrenal axis in patients with acute, chronic and episodic pain]. , 2005, Schmerz.

[64]  H. Raff,et al.  A Physiologic Approach to Diagnosis of the Cushing Syndrome , 2003, Annals of Internal Medicine.

[65]  G. Rumbaugh,et al.  Distinct effect of pregnenolone sulfate on NMDA receptor subtypes , 2001, Neuropharmacology.

[66]  L. Forman,et al.  The response to analgesia testing is affected by gonadal steroids in the rat. , 1989, Life sciences.

[67]  S. Van Uum,et al.  The effects of opioids and opioid analogs on animal and human endocrine systems. , 2010, Endocrine reviews.

[68]  Marco Bonifazi,et al.  Sex hormones, central nervous system and pain , 2006, Hormones and Behavior.

[69]  V. K. Mulgaonker,et al.  Role of testosterone on pain threshold in rats. , 1995, Indian journal of physiology and pharmacology.

[70]  J. Reul,et al.  Induction of cytokine receptors by glucocorticoids: functional and pathological significance. , 1998, Trends in pharmacological sciences.

[71]  P. Barnes,et al.  Anti-inflammatory actions of glucocorticoids: molecular mechanisms. , 1998, Clinical science.

[72]  C. Brown,et al.  Corticotropin-releasing factor modulates the immune response to stress in the rat. , 1991, Endocrinology.

[73]  E. Fibuch,et al.  The endocrine effects of long-term oral opioid therapy: a case report and review of the literature. , 2018, Journal of opioid management.

[74]  A. Mensah-Nyagan,et al.  Evidence for a key role of steroids in the modulation of pain , 2009, Psychoneuroendocrinology.

[75]  D. Abrous,et al.  Pregnenolone Sulfate and Aging of Cognitive Functions: Behavioral, Neurochemical, and Morphological Investigations , 2001, Hormones and Behavior.

[76]  S. Meyer,et al.  Funktionsstörung der hypothalamisch-hyphophysär-adrenalen Achse bei Patienten mit akuten, chronischen und intervallartigen Schmerzsyndromen , 2005, Der Schmerz.